Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

NCT00445965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Intraocular Melanoma
Lung Cancer
Melanoma (Skin)
Metastatic Cancer
Neuroblastoma
Ovarian Cancer
Retinoblastoma
Sarcoma
Small Intestine Cancer

Interventions

GENETIC: DNA analysis
OTHER: immunologic technique
OTHER: pharmacological study
RADIATION: iodine I 131 monoclonal antibody 3F8
RADIATION: 131I-3F8

Sponsor

Memorial Sloan Kettering Cancer Center